MAGL-18c attenuates LPS-induced sepsis-associated liver injury by inhibiting TGF-β/Smad signaling and remodeling medium- and long-chain fatty acid metabolism.

Front Immunol · 2026 · PMC12916367 · PMID 41727475

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although changes in MCFA and LCFA levels did not reach statistical significance, MAGL-18c showed a consistent trend toward improved lipid metabolism ( Figure 7B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.